The FDA has cleared the start of clinical trial testing of KT-621, an experimental oral medication for COPD and other ...

Columnist Caroline Gainer is concerned about a couple of results from her recent annual wellness visit that could suggest ...

Treatment with Ohtuvayre in COPD was linked to improved lung function and other benefits across key patient subgroups in ...

Dry-powder corticosteroid inhalers, or those designed to have a low impact on climate, are as effective as those based on pressurized, metered doses at reducing the risk of poor outcomes in people ...

Many of us with chronic obstructive pulmonary disease (COPD) have received medical devices to help with our breathing. At first, it seemed to me that some of these devices worked better than others.

The voice of people with chronic obstructive pulmonary disease (COPD) becomes more pitched and sounds breathy or hoarse at the early stages of disease exacerbations, which are episodes when symptoms ...

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with poorly controlled chronic obstructive pulmonary disease (COPD) and high ...

This year I’ve realized that those of us with chronic obstructive pulmonary disease (COPD) may need help accomplishing essential tasks around the home, such as yard work and housework. Maintaining our ...